Works matching Melphalan

Results: 3089

Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection.

Published in:

Pharmaceutical Development & Technology, 2018, v. 23, n. 10, p. 1024, doi. 10.1080/10837450.2016.1265557

By:

Singh, Ramsharan;
Chen, Jin;
Miller, Teresa;
Bergren, Michael;
Mallik, Rangan

Publication type:

Article

Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration.

Published in:

American Journal of Health-System Pharmacy, 2022, v. 79, n. 12, p. 1011, doi. 10.1093/ajhp/zxac055

By:

Kawedia, Jitesh D;
Ramchandran, Sumankalai;
Liu, Xiaoqian;
Gulbis, Alison M;
Titus, Mark;
Bashir, Qaiser;
Qazilbash, Muzaffar H;
Champlin, Richard E;
Ciurea, Stefan O

Publication type:

Article

Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 3, p. 579, doi. 10.1177/1078155220927436

By:

Sweiss, Karen;
Calip, Gregory Sampang;
Holden, Jaime;
Lewkowski, Paulina;
Mialik, Iryna;
Johnson, Jeremy;
Galvin, John P;
Rondelli, Damiano;
Patel, Pritesh

Publication type:

Article

Evaluating the adverse effects of melphalan formulations.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 7, p. 1631, doi. 10.1177/1078155218804042

By:

Xiang, Elaine;
Ni, Jian;
Glotzbecker, Brett;
Laubach, Jacob;
Soiffer, Robert;
McDonnell, Anne M

Publication type:

Article

Hybrid Molecules of Benzylguanidine and the Alkylating Group of Melphalan: Synthesis and Effects on Neuroblastoma Cells.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4469, doi. 10.3390/jcm12134469

By:

Bruchelt, Gernot;
Klose, Chihab;
Lischka, Matthias;
Brandes, Marietta;
Handgretinger, Rupert;
Brueckner, Reinhard

Publication type:

Article

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.

Published in:

British Journal of Clinical Pharmacology, 2016, v. 82, n. 1, p. 149, doi. 10.1111/bcp.12906

By:

Nath, Christa E.;
Trotman, Judith;
Tiley, Campbell;
Presgrave, Peter;
Joshua, Douglas;
Kerridge, Ian;
Kwan, Yiu Lam;
Gurney, Howard;
McLachlan, Andrew J.;
Earl, John W.;
Nivison‐Smith, Ian;
Zeng, Lihua;
Shaw, Peter J.

Publication type:

Article

Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen.

Published in:

Leukemia & Lymphoma, 2020, v. 61, n. 14, p. 3484, doi. 10.1080/10428194.2020.1811275

By:

Hagen, Patrick;
D'Souza, Anita;
Hari, Parameswaran;
Davila, Omar;
Zhang, Mei-Jie;
Vesole, David H.;
Smith, Scott E.;
Rodriguez, Tulio E.;
Stiff, Patrick J.

Publication type:

Article

Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015).

Published in:

Annals of Hematology, 2023, v. 102, n. 8, p. 2233, doi. 10.1007/s00277-023-05308-0

By:

Kim, Mihee;
Lee, Je-Jung;
Min, Chang-Ki;
Lee, Ji Yun;
Jo, Jae-Cheol;
Yoon, Sung-Soo;
Lim, Sung-Nam;
Do, Young Rok;
Kim, Kihyun;
Lee, Jae Hoon;
Yoo, Kwai Han;
Bae, Sung Hwa;
Yi, Jun Ho;
Jung, Jongheon;
Eom, Hyeon-Seok;
Jung, Sung-Hoon

Publication type:

Article

Long-term outcomes of busulfan plus melphalan-based versus melphalan 200 mg/m<sup>2</sup> conditioning regimens for autologous hematopoietic stem cell transplantation in patients with multiple myeloma: a systematic review and meta-analysis.

Published in:

2021

By:

Gao, Fei;
Lin, Mei-Si;
You, Jie-Shu;
Zhang, Min-Yue;
Cheng, Long;
Lin, Ke;
Zhao, Peng;
Chen, Qi-Yan

Publication type:

Literature Review

Clinical Impact of Melphalan Pharmacokinetics on Transplantation Outcomes in Children Undergoing Hematopoietic Stem Cell Transplantation.

Published in:

Cell Transplantation, 2022, v. 31, p. 1, doi. 10.1177/09636897221143364

By:

Maemura, Ryo;
Wakamatsu, Manabu;
Matsumoto, Kana;
Sakaguchi, Hirotoshi;
Yoshida, Nao;
Hama, Asahito;
Yoshida, Taro;
Miwata, Shunsuke;
Kitazawa, Hironobu;
Narita, Kotaro;
Kataoka, Shinsuke;
Ichikawa, Daisuke;
Hamada, Motoharu;
Taniguchi, Rieko;
Suzuki, Kyogo;
Kawashima, Nozomu;
Nishikawa, Eri;
Narita, Atsushi;
Okuno, Yusuke;
Nishio, Nobuhiro

Publication type:

Article

A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide.

Published in:

2010

By:

Ji, Z.;
Zhang, L.;
Peng, V.;
Ren, X.;
McHale, C. M.;
Smith, M. T.

Publication type:

journal article

Efficacy of intravitreal injections of melphalan in the treatment of retinoblastoma vitreous seeding.

Published in:

Advances in Clinical & Experimental Medicine, 2024, v. 33, n. 2, p. 119, doi. 10.17219/acem/166180

By:

Cieślik, Krzysztof;
Rogowska, Anna;
Danowska, Małgorzata;
Hautz, Wojciech

Publication type:

Article

Folate-grafted glycyl-glycine-melphalan conjugate self-assembled amphilphilc nanomicelles augmented drug delivery, cytotoxicity and cellular uptake in human ovarian cancer cells.

Published in:

Journal of Microencapsulation, 2022, v. 39, n. 3, p. 197, doi. 10.1080/02652048.2020.1714764

By:

Duan, Jie;
Chen, Ligang;
Tu, Jiao;
Cao, Li;
Xiao, Xiao

Publication type:

Article

Population Pharmacokinetics of Melphalan for Pediatric Patients Undergoing Hematopoietic Cell Transplantation.

Published in:

Journal of Clinical Pharmacology, 2022, v. 62, n. 7, p. 873, doi. 10.1002/jcph.2030

By:

Li, Shuhui;
Dvorak, Christopher C.;
Lu, Ying;
Chan, Danna;
Gobburu, Jogarao V.S.;
Long‐Boyle, Janel;
Apsel Winger, Beth

Publication type:

Article

Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2016, v. 254, n. 2, p. 391, doi. 10.1007/s00417-015-3202-0

By:

Lee, Ji;
Han, Jung;
Hahn, Seung;
Lyu, Chuhl;
Kim, Dong;
Lee, Sung

Publication type:

Article

Investigating short-term toxicity of melphalan in a model of an isolated and superfused bovine retina.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2016, v. 254, n. 1, p. 91, doi. 10.1007/s00417-015-3149-1

By:

Januschowski, Kai;
Krupp, Carlo;
Mueller, Sebastian;
Hofmann, Kathleen;
Schnichels, Sven;
Hagemann, Ulrike;
Spitzer, Martin;
Bartz-Schmidt, Karl-Ulrich;
Aisenbrey, Sabine

Publication type:

Article

A pilot study of intraoperative melphalan to prevent recurrent PVR: the IOMPVR study.

Published in:

International Journal of Retina & Vitreous, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40942-025-00675-4

By:

Moreira-Neto, Carlos A.;
Pulido, Jose S;
Gonçalves, Luca Bongiovanni de Miranda;
Cavalcanti, Gabriel Nunes;
Lima, Acacio Souza;
Neto, José de Paula Barbosa;
Lavinsky, Daniel;
de Oliveira, Talita Virginia Fernandes;
Ogata, Fernando Ejii;
Ribeiro, Lucas Zago;
Teixeira, Luiz Fernando;
do Nascimento, Flavia Borelli Gomes;
Lima, Luiz H.;
Magalhães, Octaviano Jr.;
Farah, Michel Eid;
Maia, Maurício

Publication type:

Article

Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.

Published in:

2019

By:

Xue, Kang;
Ren, Hui;
Meng, Fengxi;
Zhang, Rui;
Qian, Jiang

Publication type:

journal article

Functional analysis of the involvement of apurinic/apyrimidinic endonuclease 1 in the resistance to melphalan in multiple myeloma.

Published in:

BMC Cancer, 2014, v. 14, n. 1, p. 1, doi. 10.1186/1471-2407-14-11

By:

Jiayin Xie;
Liang Zhang;
Mengxia Li;
Jia Du;
Liwei Zhou;
Senlin Yang;
Linli Zeng;
Zengpeng Li;
Ge Wang;
Dong Wang

Publication type:

Article

Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.

Published in:

Journal of Oncology Pharmacy Practice, 2023, v. 29, n. 6, p. 1398, doi. 10.1177/10781552221125871

By:

Watson, Aleksandra N;
Shah, Shreya A;
Shalhoub, Sila D;
Piedra, Katrina M;
Komanduri, Krishna V;
Kwon, Deukwoo;
Pereira, Denise L

Publication type:

Article

Evaluating the incidence of engraftment syndrome with different melphalan formulations in adult multiple myeloma and immunoglobulin light chain amyloidosis patients undergoing autologous hematopoietic cell transplantation.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 274, doi. 10.1177/1078155220987623

By:

Kowalski, Kaitlyn E;
Wheeler, Sarah E;
Adams, C Brooke;
Voils, Stacy A;
Richards, Ashley I

Publication type:

Article

Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Published in:

Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 8, p. 1829, doi. 10.1177/1078155220904410

By:

Solana-Altabella, Antonio;
Valero, Silvia;
Balaguer, Julia;
Escobar-Cava, Paloma;
Barranco, Honorio;
López, Eduardo;
Ribes-Artero, Hugo;
Poveda, Jose Luis

Publication type:

Article

Clinical and pathomorphological changes in the rabbit retina after an injection of various doses of the cytostatic melphalan.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2023, n. 5, p. 41, doi. 10.31288/oftalmolzh202354145

By:

Bobrova, N. F.;
Sorochynska, T. A.;
Tronina, S. A.;
Romanova, T. V.;
Molachaniuk, N. I.;
Bratishko, O. Iu.;
Shylyk, A. V.

Publication type:

Article

Ultrastructural changes in the rabbit retina after various one-time doses of intravitreal melphalan.

Published in:

Journal of Ophthalmology (Ukraine) / Oftalʹmologičeskij Žurnal, 2020, n. 4, p. 50, doi. 10.31288/oftalmolzh202045055

By:

Bobrova, N. F.;
Sorochynska, T. A.;
Molachaniuk, N. I.;
Bratishko, A. Iu.

Publication type:

Article

Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma.

Published in:

Japanese Journal of Ophthalmology, 2020, v. 64, n. 4, p. 351, doi. 10.1007/s10384-020-00743-2

By:

Kiratli, Hayyam;
Koç, Irem;
Öztürk, Ebru;
Varan, Ali;
Akyüz, Canan

Publication type:

Article

Intravitreal injection of melphalan for intraocular retinoblastoma.

Published in:

Japanese Journal of Ophthalmology, 2015, v. 59, n. 3, p. 164, doi. 10.1007/s10384-015-0378-0

By:

Suzuki, Shigenobu;
Aihara, Yukiko;
Fujiwara, Miyuki;
Sano, Shuichi;
Kaneko, Akihiro

Publication type:

Article

Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.

Published in:

Japanese Journal of Ophthalmology, 2015, v. 59, n. 2, p. 109, doi. 10.1007/s10384-014-0356-y

By:

Ong, Sherine;
Chao, An-Ning;
Wong, Ho-Fai;
Liou, Kuan-Lyin;
Kao, Ling-Yuh

Publication type:

Article

Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma.

Published in:

Leukemia & Lymphoma, 2015, v. 56, n. 2, p. 415, doi. 10.3109/10428194.2014.922182

By:

Blanes, Margarita;
González, José D.;
Lahuerta, Juan J.;
Ribas, Paz;
Lorenzo, Ignacio;
Boluda, Blanca;
Sanz, Miguel A.;
de la Rubia, Javier

Publication type:

Article

Bendamustine and melphalan kill myeloma cells similarly through reactive oxygen species production and activation of the p53 pathway and do not overcome resistance to each other.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 9, p. 2165, doi. 10.3109/10428194.2013.871277

By:

Surget, Sylvanie;
Lemieux-Blanchard, Emilie;
Maïga, Sophie;
Descamps, Géraldine;
Le Gouill, Steven;
Moreau, Philippe;
Amiot, Martine;
Pellat-Deceunynck, Catherine

Publication type:

Article

A case of melphalan sustained accumulation in an 80-year old patient.

Published in:

2015

By:

Jolivot, Pierre-Alain;
Poinsignon, Vianney;
Paci, Angelo;
Guidet, Bertrand;
Pichereau, Claire;
Fernandez, Christine;
Hindlet, Patrick

Publication type:

journal article

Novel Protocol for Rapid Desensitization of Melphalan in a 5-Year-Old Boy Undergoing Conditioning for Hematopoietic Stem Cell Transplantation: A Case Report.

Published in:

Middle East Journal of Cancer, 2020, v. 11, n. 4, p. 503, doi. 10.30476/mejc.2020.82356.1081

By:

Shamsian, Bibi Shahin;
Babaie, Delara;
Naderisorki, Mohammad

Publication type:

Article

High-Dose Melphalan and Autologous Peripheral Blood Stem Cell Transplantation in AL Amyloidosis.

Published in:

Acta Haematologica, 2020, v. 143, n. 4, p. 381, doi. 10.1159/000506498

By:

Sanchorawala, Vaishali

Publication type:

Article

A systematic review of inter-individual differences in the DNA repair processes involved in melphalan monoadduct repair in relation to treatment outcomes.

Published in:

Cancer Chemotherapy & Pharmacology, 2021, v. 88, n. 5, p. 755, doi. 10.1007/s00280-021-04340-z

By:

van Kan, Maia;
Burns, Kathryn E.;
Helsby, Nuala A.

Publication type:

Article

Incidence of leukopenia and thrombocytopenia with cisplatin plus mitomycin-c versus melphalan in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Published in:

2018

By:

Hakeam, Hakeam A.;
Arab, Amal;
Azzam, Ayman;
Alyahya, Zyad;
Eldali, Abdelmoneim M.;
Amin, Tarek

Publication type:

journal article

Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up.

Published in:

In Vivo, 2025, v. 39, n. 1, p. 340, doi. 10.21873/invivo.13833

By:

RISA NISHIYAMA;
TOSHIYA KAGOO;
HIRONORI UENO;
AKIHIRO YOKOYAMA

Publication type:

Article

Targeting liposomes loaded with melphalan prodrug to tumour vasculature via the Sialyl Lewis X selectin ligand.

Published in:

Journal of Drug Targeting, 2014, v. 22, n. 3, p. 242, doi. 10.3109/1061186X.2013.862805

By:

Kuznetsova, Natalia R.;
Stepanova, Eugenia V.;
Peretolchina, Nina M.;
Khochenkov, Dmitry A.;
Boldyrev, Ivan A.;
Bovin, Nicolai V.;
Vodovozova, Elena L.

Publication type:

Article

Anesthetic management of super‑selective intra‑arterial Melphalan injection in an infant with retinoblastoma.

Published in:

Saudi Journal of Anaesthesia, 2023, v. 17, n. 3, p. 434, doi. 10.4103/sja.sja_236_23

By:

Vaithialingam, Balaji;
Gopal, Swaroop;
Chandrashekhar, Shishir;
Mallik, Dattatraya

Publication type:

Article

The Combination of Panobinostat and Melphalan for the Treatment of Patients with Multiple Myeloma.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15671, doi. 10.3390/ijms232415671

By:

Gkotzamanidou, Maria;
Terpos, Evangelos;
Dimopoulos, Meletios A.;
Souliotis, Vassilis L.

Publication type:

Article

Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14258, doi. 10.3390/ijms232214258

By:

Poczta, Anastazja;
Krzeczyński, Piotr;
Ionov, Maksim;
Rogalska, Aneta;
Gaipl, Udo S.;
Marczak, Agnieszka;
Lubgan, Dorota

Publication type:

Article

Synthesis and In Vitro Activity of Novel Melphalan Analogs in Hematological Malignancy Cells.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 3, p. 1760, doi. 10.3390/ijms23031760

By:

Poczta, Anastazja;
Krzeczyński, Piotr;
Tobiasz, Joanna;
Rogalska, Aneta;
Gajek, Arkadiusz;
Marczak, Agnieszka

Publication type:

Article

Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant.

Published in:

Pharmacotherapy, 2022, v. 42, n. 3, p. 233, doi. 10.1002/phar.2667

By:

Sivakumar, Akhilesh;
Bryson, Evan B.;
Hall, Kevin H.;
Maples, Kathryn T.;
Goyal, Subir;
Joseph, Nisha S.;
Hofmeister, Craig C.;
Kaufman, Jonathan L.;
Lonial, Sagar;
Nooka, Ajay K.;
Harvey, Robert Donald

Publication type:

Article

Melphalan induced germ cell toxicity and dose‐dependent effects of β‐aminoisobutyric acid in experimental rat model: Role of oxidative stress, inflammation and apoptosis.

Published in:

Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 8, p. 1, doi. 10.1002/jbt.23374

By:

Panghal, Archna;
Kumar, Vinod;
Jena, Gopabandhu

Publication type:

Article

Addition of intravitreal carboplatin with melphalan for management of vitreous seeding in retinoblastoma.

Published in:

Graefe's Archive of Clinical & Experimental Ophthalmology, 2023, v. 261, n. 4, p. 1167, doi. 10.1007/s00417-022-05903-3

By:

Riazi-Esfahani, Hamid;
Masoomian, Babak;
Khodabandeh, Alireza;
Amini, Abdulrahim;
Taghizadeh, Sara;
Boujabadi, Leila;
Sharifkashani, Shervin;
Shields, Carol L.;
Ghassemi, Fariba

Publication type:

Article

Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma.

Published in:

European Journal of Clinical Pharmacology, 2022, v. 78, n. 12, p. 1911, doi. 10.1007/s00228-022-03396-x

By:

Nath, Christa Ellen;
Grigg, Andrew;
Rosser, Sebastian P. A.;
Estell, Jane;
Newman, Elizabeth;
Tiley, Campbell;
Ramanathan, Sundra;
Ho, Shir Jing;
Larsen, Stephen;
Gibson, John;
Presgrave, Peter;
Shaw, Peter John;
Trotman, Judith

Publication type:

Article

Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment.

Published in:

Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6239, doi. 10.3390/jcm12196239

By:

Zhou, Shiyuan;
Zhai, Yingying;
Yan, Lingzhi;
Shi, Xiaolan;
Shang, Jingjing;
Wu, Depei;
Fu, Chengcheng;
Jin, Song

Publication type:

Article

Treatment of Multiple Myeloma and the Role of Melphalan in the Era of Modern Therapies—Current Research and Clinical Approaches.

Published in:

Journal of Clinical Medicine, 2021, v. 10, n. 9, p. 1841, doi. 10.3390/jcm10091841

By:

Poczta, Anastazja;
Rogalska, Aneta;
Marczak, Agnieszka;
Kumar, Shaji

Publication type:

Article

Evaluation of gastrointestinal complications in Egyptian patients after autologous stem cell transplantation using melphalan-based regimens.

Published in:

Egyptian Journal of Internal Medicine, 2023, v. 35, n. 1, p. 1, doi. 10.1186/s43162-023-00213-4

By:

Abdelaty, Mona Mahrous;
Al-Hosiny, Fatma;
Mashaal, Raghda Gabr

Publication type:

Article

Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders.

Published in:

British Journal of Clinical Pharmacology, 2022, v. 88, n. 1, p. 115, doi. 10.1111/bcp.14932

By:

Chandra, Sharat;
Mizuno, Kana;
Zhao, Junfang;
Davies, Stella M.;
Marsh, Rebecca A.;
Fukuda, Tsuyoshi;
Setchell, Kenneth D. R.;
Vinks, Alexander A.;
Mehta, Parinda A.

Publication type:

Article

Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML.

Published in:

Cancers, 2024, v. 16, n. 16, p. 2859, doi. 10.3390/cancers16162859

By:

Fraccaroli, Alessia;
Stauffer, Elena;
Haebe, Sarah;
Prevalsek, Dusan;
Weiss, Lena;
Dorman, Klara;
Drolle, Heidrun;
von Bergwelt-Baildon, Michael;
Stemmler, Hans-Joachim;
Herold, Tobias;
Tischer, Johanna

Publication type:

Article

Prognostic Factors for Postoperative Bleeding Complications and Prolonged Intensive Care after Percutaneous Hepatic Chemosaturation Procedures with Melphalan.

Published in:

Cancers, 2023, v. 15, n. 15, p. 3776, doi. 10.3390/cancers15153776

By:

Struck, Manuel Florian;
Werdehausen, Robert;
Kirsten, Holger;
Gössmann, Holger;
Veelken, Rhea;
van Bömmel, Florian;
Stehr, Sebastian;
Denecke, Timm;
Ebel, Sebastian

Publication type:

Article